Global Companion Diagnostic Tests Market Research Report 2021
- Published Date: 2021-04-15
- Report ID: 93680
- Pages: 88
-
Format:
Prudent Markets Predicts that Companion Diagnostic Tests Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Companion Diagnostic Tests Market Overview:
Global Companion Diagnostic Tests Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Companion Diagnostic Tests involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Companion Diagnostic Tests Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Companion Diagnostic Tests market in 2020.
Global Companion Diagnostic Tests Market Segmentation
By Type, Companion Diagnostic Tests market has been segmented into:
Protein Detection
DNA Detection
Hybridization
Biomarker
Others
By Application, Companion Diagnostic Tests market has been segmented into:
Pharmaceutical and Biotechnology Companies
Medical Device Companies
Research Institutes
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Companion Diagnostic Tests market are:
F. Hoffman LA Roche Ltd.
QIAGEN
Illumina
Inc.
Abbott
Agilent Technologies
Inc.
Genomic Health
Inc.
Biomerieux
BioGenex
AGENDIA NV
Siemens Healthcare GmBH
Thermo Fisher Scientific
Inc.
1. Market Overview of Companion Diagnostic Tests
1.1 Companion Diagnostic Tests Market Overview
1.1.1 Companion Diagnostic Tests Product Scope
1.1.2 Market Status and Outlook
1.2 Companion Diagnostic Tests Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Companion Diagnostic Tests Historic Market Size by Regions (2015-2020)
1.4 Companion Diagnostic Tests Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Companion Diagnostic Tests Sales Market by Type (2015-2026)
2.1 Global Companion Diagnostic Tests Historic Market Size by Type (2015-2020)
2.2 Global Companion Diagnostic Tests Forecasted Market Size by Type (2021-2026)
2.3 Protein Detection
2.4 DNA Detection
2.5 Hybridization
2.6 Biomarker
2.7 Others
3. Covid-19 Impact Companion Diagnostic Tests Sales Market by Application (2015-2026)
3.1 Global Companion Diagnostic Tests Historic Market Size by Application (2015-2020)
3.2 Global Companion Diagnostic Tests Forecasted Market Size by Application (2021-2026)
3.3 Pharmaceutical and Biotechnology Companies
3.4 Medical Device Companies
3.5 Research Institutes
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Companion Diagnostic Tests Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Companion Diagnostic Tests Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Companion Diagnostic Tests Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Companion Diagnostic Tests Business
5.1 F. Hoffman LA Roche Ltd.
5.1.1 F. Hoffman LA Roche Ltd. Company Profile
5.1.2 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Product Specification
5.1.3 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 QIAGEN
5.2.1 QIAGEN Company Profile
5.2.2 QIAGEN Companion Diagnostic Tests Product Specification
5.2.3 QIAGEN Companion Diagnostic Tests Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Illumina
5.3.1 Illumina Company Profile
5.3.2 Illumina Companion Diagnostic Tests Product Specification
5.3.3 Illumina Companion Diagnostic Tests Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Inc.
5.4.1 Inc. Company Profile
5.4.2 Inc. Companion Diagnostic Tests Product Specification
5.4.3 Inc. Companion Diagnostic Tests Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Abbott
5.5.1 Abbott Company Profile
5.5.2 Abbott Companion Diagnostic Tests Product Specification
5.5.3 Abbott Companion Diagnostic Tests Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Agilent Technologies
5.6.1 Agilent Technologies Company Profile
5.6.2 Agilent Technologies Companion Diagnostic Tests Product Specification
5.6.3 Agilent Technologies Companion Diagnostic Tests Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Inc.
5.7.1 Inc. Company Profile
5.7.2 Inc. Companion Diagnostic Tests Product Specification
5.7.3 Inc. Companion Diagnostic Tests Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Genomic Health
5.8.1 Genomic Health Company Profile
5.8.2 Genomic Health Companion Diagnostic Tests Product Specification
5.8.3 Genomic Health Companion Diagnostic Tests Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Inc.
5.9.1 Inc. Company Profile
5.9.2 Inc. Companion Diagnostic Tests Product Specification
5.9.3 Inc. Companion Diagnostic Tests Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Biomerieux
5.10.1 Biomerieux Company Profile
5.10.2 Biomerieux Companion Diagnostic Tests Product Specification
5.10.3 Biomerieux Companion Diagnostic Tests Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 BioGenex
5.11.1 BioGenex Company Profile
5.11.2 BioGenex Companion Diagnostic Tests Product Specification
5.11.3 BioGenex Companion Diagnostic Tests Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 AGENDIA NV
5.12.1 AGENDIA NV Company Profile
5.12.2 AGENDIA NV Companion Diagnostic Tests Product Specification
5.12.3 AGENDIA NV Companion Diagnostic Tests Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Siemens Healthcare GmBH
5.13.1 Siemens Healthcare GmBH Company Profile
5.13.2 Siemens Healthcare GmBH Companion Diagnostic Tests Product Specification
5.13.3 Siemens Healthcare GmBH Companion Diagnostic Tests Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Thermo Fisher Scientific
5.14.1 Thermo Fisher Scientific Company Profile
5.14.2 Thermo Fisher Scientific Companion Diagnostic Tests Product Specification
5.14.3 Thermo Fisher Scientific Companion Diagnostic Tests Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Inc.
5.15.1 Inc. Company Profile
5.15.2 Inc. Companion Diagnostic Tests Product Specification
5.15.3 Inc. Companion Diagnostic Tests Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Companion Diagnostic Tests Market Size (2015-2026)
6.2 North America Companion Diagnostic Tests Key Players in North America (2015-2020)
6.3 North America Companion Diagnostic Tests Market Size by Type (2015-2020)
6.4 North America Companion Diagnostic Tests Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Companion Diagnostic Tests Market Size (2015-2026)
7.2 East Asia Companion Diagnostic Tests Key Players in North America (2015-2020)
7.3 East Asia Companion Diagnostic Tests Market Size by Type (2015-2020)
7.4 East Asia Companion Diagnostic Tests Market Size by Application (2015-2020)
8. Europe
8.1 Europe Companion Diagnostic Tests Market Size (2015-2026)
8.2 Europe Companion Diagnostic Tests Key Players in North America (2015-2020)
8.3 Europe Companion Diagnostic Tests Market Size by Type (2015-2020)
8.4 Europe Companion Diagnostic Tests Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Companion Diagnostic Tests Market Size (2015-2026)
9.2 South Asia Companion Diagnostic Tests Key Players in North America (2015-2020)
9.3 South Asia Companion Diagnostic Tests Market Size by Type (2015-2020)
9.4 South Asia Companion Diagnostic Tests Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Companion Diagnostic Tests Market Size (2015-2026)
10.2 Southeast Asia Companion Diagnostic Tests Key Players in North America (2015-2020)
10.3 Southeast Asia Companion Diagnostic Tests Market Size by Type (2015-2020)
10.4 Southeast Asia Companion Diagnostic Tests Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Companion Diagnostic Tests Market Size (2015-2026)
11.2 Middle East Companion Diagnostic Tests Key Players in North America (2015-2020)
11.3 Middle East Companion Diagnostic Tests Market Size by Type (2015-2020)
11.4 Middle East Companion Diagnostic Tests Market Size by Application (2015-2020)
12. Africa
12.1 Africa Companion Diagnostic Tests Market Size (2015-2026)
12.2 Africa Companion Diagnostic Tests Key Players in North America (2015-2020)
12.3 Africa Companion Diagnostic Tests Market Size by Type (2015-2020)
12.4 Africa Companion Diagnostic Tests Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Companion Diagnostic Tests Market Size (2015-2026)
13.2 Oceania Companion Diagnostic Tests Key Players in North America (2015-2020)
13.3 Oceania Companion Diagnostic Tests Market Size by Type (2015-2020)
13.4 Oceania Companion Diagnostic Tests Market Size by Application (2015-2020)
14. South America
14.1 South America Companion Diagnostic Tests Market Size (2015-2026)
14.2 South America Companion Diagnostic Tests Key Players in North America (2015-2020)
14.3 South America Companion Diagnostic Tests Market Size by Type (2015-2020)
14.4 South America Companion Diagnostic Tests Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Companion Diagnostic Tests Market Size (2015-2026)
15.2 Rest of the World Companion Diagnostic Tests Key Players in North America (2015-2020)
15.3 Rest of the World Companion Diagnostic Tests Market Size by Type (2015-2020)
15.4 Rest of the World Companion Diagnostic Tests Market Size by Application (2015-2020)
16 Companion Diagnostic Tests Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
